TrialJournal of clinical hypertension (Greenwich, Conn.)2015

Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

Ulrike Raff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.